glp-1 agonists pill Popular obesity drug fails in hotly anticipated Alzheimer's trials | Science FDA approves Foundayo, an oral
Description
Information or Data Analysis 1.3.3
R., Martins, O
Key References Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al
Safety concerns include gastrointestinal issues, potential aspiration risk, and rare anaphylactic reactions
GLP-1RAs pose risks of severe eye complications, particularly worsening diabetic retinopathy with rapid and significant HbA1c reduction
What is more, it seems that GLP-1R agonists may be useful as an adjunctive to traditional therapy to treat cognitive impairments observed in the course of depression, especially in women
